首页 / 院系成果 / 成果详情页

The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer  期刊论文  

  • 编号:
    d421cd2f-573c-4527-8d84-b4d4d0f5205e
  • 作者:
    Ding, Xiaojie(丁晓洁)#[1,2,3]Qiu, Lijuan#[1,2,3]Zhang, Lijuan(张丽娟)[4]Xi, Juemin[1,2,3];Li, Duo[1,2,3];Huang, Xinwei[1,2,3];Zhao, Yujiao[1,2,3];Wang, Xiaodang[1,2,3];Sun, Qiangming*[1,2,3]
  • 语种:
    英文
  • 期刊:
    ONCOTARGETS AND THERAPY ISSN:1178-6930 2016 年 9 卷 (1189 - 1204)
  • 收录:
  • 关键词:
  • 摘要:

    Background: Semaphorin 4D (Sema4D) belongs to the class IV semaphorins, and accumulating evidence has indicated that its elevated level may be one strategy by which tumors evade current antiangiogenic therapies. The biological roles of Sema4D in colorectal cancer (CRC), however, remain largely undefined. This study was designed to investigate the effects of Sema4D on tumor angiogenesis and growth in CRC, especially in different vascular endothelial growth factor (VEGF) backgrounds.
    Methods: The expression of Sema4D in human CRC was evaluated by immunohistochemical analysis of tumors and their matching normal control tissues. The expression level of Sema4D and VEGF was investigated in different CRC cell lines. To evaluate the contributions of Sema4D to tumor-induced angiogenesis, two CRC cell lines with opposite VEGF backgrounds were infected with lentiviruses expressing Sema4D or Sema4D short hairpin RNA, followed by in vitro migration and in vivo tumor angiogenic assays.
    Results: Immunohistochemical analysis of human CRC revealed high levels of Sema4D in a cell surface pattern. In all, 84.85% of CRC samples analyzed exhibited moderate to strong Sema4D expression. The positive ratios of Sema4D staining for well, moderately, and poorly differentiated cancers were 71.43%, 96.67%, and 77.27%, respectively. Sema4D is highly expressed in five different CRC cell lines, while VEGF expression level varies among these cell lines. HCT-116 showed the lowest VEGF level, while Caco-2 showed the maximum VEGF level. In vitro migration results show that regardless of cell type and VEGF background, Sema4D showed an enhanced in vitro proangiogenic effect to induce the migration of human umbilical vein endothelial cells. Finally, in vivo tumor angiogenic assays demonstrated that Sema4D alone can elicit a significant angiogenic response to promote tumor growth independently of VEGF.
    Conclusion: Targeting Sema4D might serve as a parallel option for antiangiogenic therapy for CRC, particularly when traditional anti-VEGF therapies fail or tumors develop resistance to strategies targeting a single angiogenic signaling pathway.

  • 推荐引用方式
    GB/T 7714:
    Ding Xiaojie,Qiu Lijuan,Zhang Lijuan, et al. The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer [J].ONCOTARGETS AND THERAPY,2016,9:1189-1204.
  • APA:
    Ding Xiaojie,Qiu Lijuan,Zhang Lijuan,Xi Juemin,&Sun Qiangming.(2016).The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer .ONCOTARGETS AND THERAPY,9:1189-1204.
  • MLA:
    Ding Xiaojie, et al. "The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer" .ONCOTARGETS AND THERAPY 9(2016):1189-1204.
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:37 下载次数:0
浏览次数:37
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部